Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion type Assertion NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_head.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion description "[The effect of the PI3K/PTEN/AKT/mTOR signaling pathway on cancer treatment, including NSCLC, has been well documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_provenance.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion evidence source_evidence_literature NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_provenance.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion SIO_000772 20447721 NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_provenance.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion wasDerivedFrom befree-20140225 NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_provenance.
- NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_assertion wasGeneratedBy ECO_0000203 NP162335.RAKtf-AvBCsXjYmF4kGYl4oWHUAvXFCBqO53-mcyASCLg130_provenance.